- Home
- QURE vs AAP Comparison
QURE vs AAP Comparison
Compare QURE & AAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QURE | AAP |
|---|---|---|
| Founded | 1998 | 1929 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto & Home Supply Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.4B |
| IPO Year | 2013 | 2002 |
Fundamental Metrics
Financial Performance| Metric | QURE | AAP |
|---|---|---|
| Price | $22.42 | $46.97 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 25 |
| Target Price | ★ $61.24 | $49.95 |
| AVG Volume (30 Days) | ★ 2.5M | 1.5M |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 2.14% |
| EPS Growth | 29.67 | ★ 113.01 |
| EPS | N/A | ★ 1.31 |
| Revenue | $13,107,000.00 | ★ $8,601,000,000.00 |
| Revenue This Year | $54.78 | N/A |
| Revenue Next Year | $356.14 | $2.24 |
| P/E Ratio | ★ N/A | $35.55 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $37.89 |
| 52 Week High | $71.50 | $65.20 |
Technical Indicators
Market Signals| Indicator | QURE | AAP |
|---|---|---|
| Relative Strength Index (RSI) | 28.08 | 66.67 |
| Support Level | $22.32 | $46.84 |
| Resistance Level | $25.61 | $60.02 |
| Average True Range (ATR) | 1.19 | 1.52 |
| MACD | 0.75 | 0.81 |
| Stochastic Oscillator | 57.58 | 97.01 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About AAP Advance Auto Parts Inc.
Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.